Literature DB >> 11398081

Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.

M Hoshino1, Y Nakamura, Q A Hamid.   

Abstract

BACKGROUND: Angiogenesis is a feature of airway remodeling in bronchial asthma. The mechanism responsible for this angiogenesis is unknown. Vascular endothelial growth factor (VEGF) is a potent inducer of endothelial cells, which may contribute to chronic inflammation and angiogenesis.
OBJECTIVE: We sought to investigate the molecular mechanisms underlying increased vascularity, and we examined the mRNA expression of VEGF and its receptors (flt-1 and flk-1) within bronchial biopsy specimens from asthmatic patients and normal control subjects.
METHODS: Endobronchial biopsy specimens were examined immunocytochemically by staining with anti-type IV collagen mAb to evaluate vessel density by using computer-assisted image analysis. Specimens were also analyzed for the presence of the mRNAs of VEGF and its receptors with in situ hybridization.
RESULTS: The extent of airway vascularity was increased in asthmatic subjects compared with that in control subjects (P <.01). Asthmatic subjects exhibited a greater expression of VEGF, flt-1, and flk-1 mRNA(+) cells in the airway mucosa compared with that in control subjects (P <.001 for each comparison). The degree of vascularity was associated with the number of VEGF, flt-1, and flk-1 mRNA(+) cells. Numbers of cells expressing VEGF mRNA inversely correlated with airway caliber (r = -0.83, P <.01) and airway hyperresponsiveness (r = -0.97, P <.001). Colocalization studies showed that macrophages, eosinophils, and CD34(+) cells were the major sources of VEGF; CD34(+) cells, macrophages, and T cells expressed both flt-1 and flk-1.
CONCLUSION: These findings provide evidence that VEGF may play an important role in angiogenesis and subsequent airway remodeling in bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11398081     DOI: 10.1067/mai.2001.115626

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  66 in total

1.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

Review 2.  Pharmacotherapy and airway remodelling in asthma?

Authors:  P A Beckett; P H Howarth
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 3.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

4.  Blanching the airways: steroid effects in asthma.

Authors:  Alan J Knox; Karl Deacon; Rachel Clifford
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

Review 5.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

6.  Lung gene expression in a rhesus allergic asthma model correlates with physiologic parameters of disease and exhibits common and distinct pathways with human asthma and a mouse asthma model.

Authors:  Alexander R Abbas; Janet K Jackman; Sherron L Bullens; Sarah M Davis; David F Choy; Grazyna Fedorowicz; Martha Tan; Bao-Tran Truong; Y Gloria Meng; Lauri Diehl; Lisa A Miller; Edward S Schelegle; Dallas M Hyde; Hilary F Clark; Zora Modrusan; Joseph R Arron; Lawren C Wu
Journal:  Am J Pathol       Date:  2011-08-03       Impact factor: 4.307

Review 7.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

8.  A network-based gene-weighting approach for pathway analysis.

Authors:  Zhaoyuan Fang; Weidong Tian; Hongbin Ji
Journal:  Cell Res       Date:  2011-09-06       Impact factor: 25.617

9.  Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion.

Authors:  Seong Hwan Choi; Eun Young Park; Hye Lim Jung; Jae Won Shim; Deok Soo Kim; Moon Soo Park; Jung Yeon Shim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

10.  Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.

Authors:  Jeong-Hee Choi; Yu-Jin Suh; Soo-Keol Lee; Chang-Hee Suh; Dong-Ho Nahm; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.